Core Scientific’s valuation in the acquisition offer by CoreWeave stands at $20.40 per share as of July 2025, reflecting a 66% premium over its stock price in late June 2025 before news of the deal emerged.

Quotes that support claims

The transaction values Core Scientific’s stock at $20.40 per share, according to a statement from CoreWeave on Monday. That represents a 66% premium over the closing price on June 25, the trading day before the Wall Street Journal reported that the two companies were in advanced talks.

The deal values Core Scientific shares at $20.40, a 66% premium to its price late last month, with each Core Scientific share being swapped for 0.1235 CoreWeave shares.